H19 promotes HCC bone metastasis by reducing osteoprotegerin (OPG) expression, which is mediated by Protein Phosphatase 1 Catalytic subunit alpha (PPP1CA)-induced inactivation of the p38/MAPK pathway along with sponging miR-200b-3p [54]. Here, H19 is linked to hepatocellular carcinoma.